1-Methyl-4-(Piperidin-4-yl)-Piperazine: A Key Intermediate for Brigatinib Synthesis

Essential building block for targeted cancer therapies and advanced pharmaceutical applications.

Get a Quote & Sample

Advantages Offered by the Product

High Purity and Consistency

Guaranteed high purity levels are essential for sensitive pharmaceutical applications, ensuring reliable outcomes in complex synthetic processes, a key characteristic of this 1-methyl-4-piperidin-4-yl-piperazine intermediate.

Critical for Targeted Therapies

Its role as a Brigatinib synthesis intermediate underscores its importance in creating life-saving targeted cancer therapies, directly contributing to patient treatment options.

Versatile in Organic Synthesis

Beyond its primary application, this compound's structure makes it a valuable building block in broader organic synthesis, supporting research and development in medicinal chemistry.

Key Applications

Pharmaceutical Intermediate

Used extensively in the synthesis of active pharmaceutical ingredients (APIs), particularly in the development of anti-cancer drugs like Brigatinib, utilizing its role as a 1-methyl-4-piperidin-4-yl-piperazine intermediate.

Drug Research and Development

Acts as a vital chemical reagent and building block in medicinal chemistry labs for exploring new drug candidates and optimizing synthesis routes, often searching for CAS 53617-36-0.

Fine Chemical Manufacturing

Essential component in the production of fine chemicals, supporting industries that require high-specification organic compounds for various advanced applications.

Targeted Cancer Therapy Synthesis

Specifically crucial for the multi-step synthesis of Brigatinib, a drug targeting specific cancer mutations, highlighting its significance in the oncology sector.